The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd

Hyperion Investments Pte. Ltd. 83 Clemenceau Avenue, #11-01 UE Square, Singapore 239920 TEL +65 6390-5000 13 August 2026 1. Department of Corporate Services, BSE Limited Floor 25, P J Towers, Dalal Street, Mumbai - 400 001 2. National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 3. cc: Dr. Agarwal’s Health Care Limited 1st Floor, Buhari Towers, No. 4, Moores Road, off Greams Road, Near Asan Memorial School, Chennai, Tamil Nadu 600006 Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir/Ma’am, We, Hyperion Investments Pte. Ltd., write in our capacity as a shareholder of Dr. Agarwal’s Health Care Limited (“Company”). Enclosed is a disclosure under Regulation 29 (2) of the Takeover Code for the sale of 24,160,000 equity shares of the Company. We request you to take the same on record and acknowledge the same. Yours faithfully, For Hyperion Investments Pte. Ltd. Authorized Signatory Name: Pham Quynh Chi Hyperion Investments Pte. Ltd. 83 Clemenceau Avenue, #11-01 UE Square, Singapore 239920 TEL +65 6390-5000 Disclosure under Regulation 29(2) of SEBl (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company Dr. Agarwal’s Health Care Limited (TC) Name(s) of the acquirer and Hyperion Investments Pte. Ltd. acting in its capacity as a Persons Acting in Concert (PAC) shareholder of the Target Company with the acquirer Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock BSE Limited and National Stock Exchange of India Limited Exchange(s) where the shares of TC are Listed % w .r.t. % w.r.t. total total diluted share/voting Details of the share/voting Number capital acquisition/disposal as follows capital of the wherever applicable(*) (**) Before the acquisition/ 73,193,988 23.09 22.93 disposal under consideration, holding of: (a) Shares carrying voting rights (b) Shares in the nature of Nil Nil Nil encumbrance (pledge/ lien/ non-disposal undertaking/ others) (c) Voting rights (VR) Nil Nil Nil otherwise than by equity shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) (e) Total (a+b+c+d) 73,193,988 23.09 22.93 Details of acquisition/sale 24,160,000 7.62 7.57 Hyperion Investments Pte. Ltd. 83 Clemenceau Avenue, #11-01 UE Square, Singapore 239920 TEL +65 6390-5000 (a) Shares carrying voting rights acquired / sold (b) VRs acquired / sold Nil Nil Nil otherwise than by shares (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold (d) Shares encumbered / Nil Nil Nil invoked / released by the acquirer (e) Total (a+b+c+/-d) 24,160,000 7.62 7.57 After the acquisition/sale, 49,033,988 15.47 15.36 holding of: (a) Shares carrying voting rights (b) Shares encumbered with Nil Nil Nil the acquirer (c) VRs otherwise than by Nil Nil Nil shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition (e) Total (a+b+c+d) 49,033,988 15.47 15.36 Mode of acquisition/sale (e.g. Sale of shares through the stock exchanges open market / off-market / public issue / rights issue / preferential allotment / inter se transfer etc.) Date of acquisition/ sale of 12 August 2026 (date of sale) shares/ VR or date of receipt of Hyperion Investments Pte. Ltd. 83 Clemenceau Avenue, #11-01 UE Square, Singapore 239920 TEL +65 6390-5000 intimation of allotment of shares, whichever is applicable. Equity share capital / total voting 316,983,028 fully paid up equity shares of INR 1/- each capital of the TC before the said acquisition / sale Equity share capital/ total voting 316,983,028 fully paid up equity shares of INR 1/- each capital of the TC after the said acquisition / sale Total diluted share/voting capital 319,262,876 fully paid up equity shares of INR 1/- each of the TC after the said acquisition / sale Hyperion Investments Pte. Ltd. 83 Clemenceau Avenue, #11-01 UE Square, Singapore 239920 TEL +65 6390-5000 For Hyperion Investments Pte. Ltd. Signature of the Authorised Signatory Name: Pham Quynh Chi Designation: Director Place: Singapore Date: 13 August 2026 Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.